-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

626.O1.6 626. Aggressive Lymphomas: Prospective Therapeutic Trials: Initial treatment strategies in aggressive B Cell lymphomas Clinically Relevant Abstract

Symposia: Aggressive Lymphomas: Prospective Therapeutic Trials Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Biological therapies, Antibody Therapy, Bispecific Antibody Therapy, Non-Biological therapies, Clinical Research, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Chemotherapy, Checkpoint Inhibitor, Diseases, Therapies, therapy sequence, Lymphoid Malignancies, Technology and Procedures, molecular testing
Monday, December 11, 2023: 2:45 PM-4:15 PM
Seaport Ballroom ABCD (Manchester Grand Hyatt San Diego)
Moderators:
Hua-Jay J Cherng, MD, Columbia University and Annalisa Chiappella, MD, Fondazione IRCCS Istituto Nazionale dei Tumori
Disclosures:
Chiappella: Gilead-Sciences: Other: lecture fee/educational activities, advisory board; Novartis: Other: lecture fee/educational activities; Celgene-BMS: Other: lecture fee/educational activities, advisory board; SecuraBIO: Other: advisory board; Incyte: Other: lecture fee/educational activities; AstraZeneca: Other: lecture fee/educational activities; Jannsen-Cilag: Other: lecture fee/educational activities, advisory board; Roche: Other: lecture fee/educational activities, advisory board; Ideogen: Other: advisory board; Takeda: Other: lecture fee/educational activities, advisory board.
2:45 PM

Clementine Sarkozy1*, Thierry Jo Molina, MD, PhD2*, Roch Houot, MD, PhD3*, Sydney Dubois, BS, MSc4*, Gian Matteo Pica, MD5*, Philippe Ruminy6*, Charles Herbaux, MD, PhD7*, Thomas Gastinne, MD8*, Corinne Haioun, MD, PhD9, Stephanie Guidez10*, Christophe Bonnet, MD, PhD11*, Marc Andre, MD12*, Liana Vereseza4*, Choquet Sylvain13*, Loic Ysebaert, MD, PhD14*, Emmanuel Bachy, MD, PhD15*, Fabrice Jardin, MD PhD16*, Franck Morschhauser, MD PhD17 and Vincent Ribrag, MD18

1Hematology departement, institut Curie, Paris, France
2Necker enfants malades, APHP, Paris, Paris, FRA
3CHU de Rennes, Rennes, France
4Centre Henri Becquerel, Rouen, France
5Hematology department, CH Chambery, Chambery, France
6Centre henri Becquerel, Rouen, FRA
7Faculty of Medicine, University of Montpellier, Montpellier, France
8Hématologie, Hôpital Hôtel Dieu, Nantes Cedex 1, France
9Lymphoid Malignancies Department, Henri Mondor University Hospital, AP-HP, Créteil, France
10CHU de Poitiers, Poitiers, FRA
11Hematology Department, CHU Liège, Liège, Belgium
12Department of Hematology, Clinique de Mont-Godinne, Yvoir, Belgium
13Hopital de la Pitié Salpetrière, APHP, Paris, FRA
14Hematology Department, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
15Lyon-Sud Hospital Center, Pierre-Bénite, France
16Centre Henri Becquerel, Rouen, FRA
17Hôpital Claude Huriez Univ. Lille, CHU Lille, Lille, France
18Département d'Innovation Thérapeutique et d'Essais Précoces (DITEP), Gustave Roussy Institute of Cancer,, Villejuif, France

3:00 PM

Jillian Simard, MD1*, James D Phelan, PhD1*, Christopher Melani, MD1, Rahul Lakhotia, MBBS1, Stefania Pittaluga, MD, PhD2*, Jagan R. Muppidi, MD, PhD1*, Michail Lionakis, MD, ScD3*, Cody J Peer4*, Amynah Pradhan, NP1*, Matthias Holdhoff, MD5*, Lode J. Swinnen6, Kieron Dunleavy, MD7*, Catherine Lai, MD8, Sami Ibrahimi, MD9*, Michael Glantz10*, John A Butman11*, Kim Johnson, RN12*, Seth M. Steinberg, PhD13*, William Figg, PharmD14*, Elaine S. Jaffe, MD15, Louis M. Staudt, MD, PhD1, Wyndham H. Wilson, MD, PhD1* and Mark Roschewski, MD1

1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
2Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD
3Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
4Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
5Department of Neuro-Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
6Johns Hopkins Cancer Center, Baltimore, MD
7Medstar Georgetown University Hospital, Washington, DC
8Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
9University of Oklahoma Health Sciences Center, Oklahoma City, OK
10Department of Neurosurgery, Penn State College of Medicine, Hershey Medical Center, Hershey, PA
11Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD
12Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD
13Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, MD
14Molecular Pharmacology Section, Genitourinary Malignancies Section, Center for Cancer Research, National Cancer Institute,, National Institutes of Health, Bethesda, MD
15CCR Lab of Pathology, National Cancer Institute, Bethesda, MD

3:15 PM

Adam J Olszewski, MD1, Herbert Eradat, MD2*, Abraham Avigdor, MD3,4, Netanel A. Horowitz, MD5*, Sunil Babu, MD6*, Itai Levi, MD7*, Matthew McKinney, MD8*, Seung Tae Lee, MD9, Juan Miguel Bergua Burgues10*, Antonia Rodriguez Izquierdo, MD11*, Mariana Bastos-Oreiro, MD12*, Chezi Ganzel, MD13,14*, Tae Min Kim, MD, PhD15*, Youngwoo Jeon, MD16*, Michal Taszner17*, Mayur Narkhede, MD18*, Won Seog Kim, MD19*, Ho-Jin Shin, MD20*, David Lavie21*, Dariusz Woszczyk, MD22*, Diana Dunshee23*, Amy V. Kapp, PhD23*, Mingzhu Zhou, MD24*, Connie Lee Batlevi, MD23*, Wahib Ead, PharmD23*, Gila Sellam, PhD25* and Wojciech Jurczak, MD, PhD26

1Brown University, Providence, RI
2University of California, Los Angeles, CA
3Sheba Medical Center, Ramat Gan, Israel
4School of Medicine, Tel Aviv University, Tel Aviv, Israel
5Rambam Health Care Campus, Technion, Haifa, Israel
6Fort Wayne Medical Oncology and Hematology, Fort Wayne, IN
7Soroka University Medical Centre, Be’er-Sheva, Israel
8Duke Cancer Institute, Durham, NC
9University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
10Hematology and Hemotherapy Service, San Pedro de Alcántara Hospital, Cáceres, Spain
11University Hospital October 12, Madrid, Spain
12Hospital General Universitario Gregorio Marañón, Madrid, Spain
13Hematology Department, Shaare Zedek Medical Center, Jerusalem, Israel
14Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
15Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
16Lymphoma and Cell Therapy-Research Center, Yeouido, ST. Mary’s Hospital, Seoul, Korea, Republic of (South)
17Department of Hematology and Transplantology, University Clinical Center, Medical University of Gdańsk, Gdańsk, Poland
18University of Alabama at Birmingham, Birmingham, AL
19Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
20Division of Hematology-Oncology, Department of Internal Medicine, Biochemical Research Institution, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea, Republic of (South)
21Hadassah Medical Center, Jerusalem, Israel
22University of Opole, Provincial Hospital, Opole, Poland
23Genentech, Inc., South San Francisco, CA
24F. Hoffmann-La Roche Ltd, Shanghai, China
25F. Hoffmann-La Roche Ltd, Basel, Switzerland
26Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland

3:30 PM

Jason Westin, MD1, Raphael E Steiner, MD2*, Dai Chihara, MD, PhD3, Sairah Ahmed, MD3, Preetesh Jain, MD, MBBS, PhD, DM4, Luis Malpica, MD4*, Swami P. Iyer, MD4, Luis Fayad, MD5, Ranjit Nair, MD6, Loretta J. Nastoupil, MD7, Sattva S. Neelapu, MD8, Jared Henderson9*, Maria Alma Rodriguez, MD4*, F. B. Hagemeister, MD10, Francisco Vega, MD, PhD11, Brittani Pulsifer, APRN12*, Jisha Tom, APRN12*, Isak Durmic12*, Gita Masand3*, Lei Feng, MS13*, Michael R. Green, PhD14, Christopher R. Flowers, MD, MS3 and Paolo Strati, MD3

1Department of Lymphoma & Myeloma, M.D. Anderson Cancer Center, Houston, TX
2Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston
3Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
4Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
5Lymphoma/Myeloma, M.D. Anderson Cancer Center, Houston, TX
6Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Pearland, TX
7MD Anderson Cancer Center, Houston, TX
8M.D. Anderson Cancer Center, Houston, TX
9Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
10University of Texas MD Anderson Cancer Center, Houston, TX
11Department of Hematopathology, MD Anderson Cancer Center , Houston, TX
12Lymphoma & Myeloma, MD Anderson Cancer Center, Houston, TX
13Biostatistics, UT MD Anderson Cancer Center, Houston, TX
14Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Friendswood, TX

3:45 PM

Zhiyong Zeng, MD1*, Apeng Yang2*, Yuanxiang Lin3* and Junmin Chen3*

1The First Affiliated Hospital of Fujian Medical University, Fuzhou,Fujian Province,China, China
2The First Affiliated Hospital of Fujian Medical University, Fuzhou,Fujian Province, CHN
3The First Affiliated Hospital of Fujian Medical University, Fuzhou,Fujian Province, China

4:00 PM

Lorenzo Falchi, MD1, Fabrice Jardin, MD PhD2*, Corinne Haioun, MD3*, Tomasz Wrobel, MD, PhD4*, Judit Mészáros Joergensen, MD, PhD5*, Mariana Bastos-Oreiro, MD6*, Eric Mou, MD7*, Joaquin Martinez-Lopez, MD, PhD8*, Elizabeth Lihua Elizabeth Budde, MD, PhD9, Nancy L. Bartlett, MD10, Jan M. Zaucha11*, Alejandro Martin Garcia-Sancho, MD12*, Rutanshu Shah, PharmD MD13*, Nathan Rees, BSc14*, Ron McCord, PhD13*, Alexandra Bazeos, MD15*, Maneesh Tandon, MBChB14*, Michelle Doral, BSc13*, Ethan Troy-Barnes, MBBCh BAO MD14* and Marcel Nijland, MD PhD16*

1Memorial Sloan Kettering Cancer Center, New York, NY
2Centre Henri Becquerel, Rouen, France
3Henri-Mondor University Hospital, Créteil, France
4Wrocław Medical University, Wrocław, Poland
5Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
6Hospital General Universitario Gregorio Marañón, Madrid, Spain
7University of Iowa, Iowa City, IA
8Centro Nacional de Investigaciones Oncológicas, Madrid, Spain
9City of Hope National Medical Center, Duarte, CA
10Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
11Medical University of Gdansk, Gdansk, Poland
12Hospital Universitario de Salamanca, Salamanca, Spain
13Genentech, Inc., South San Francisco, CA
14Roche Products Ltd, Welwyn Garden City, United Kingdom
15F. Hoffmann-La Roche Ltd, Basel, Switzerland
16Department of Hematology, University Medical Center Groningen, Groningen, Netherlands

*signifies non-member of ASH